To Main Menu ► 

Diabetes Bites

/Diabetes Bites

Exercise and Type 1 Diabetes: JDRF PEAK Program

By | March 17th, 2017|Diabetes Bites, March 2017 Newsletter|

How to exercise safely with type 1 diabetes: JDRF PEAK is a program meant to share information about just that! This program is a collaboration of JDRF with researchers around the world meant to address a missing piece in type 1 care and education.

Analysis of accuracy for the Freestyle Libre glucose monitor

By | March 16th, 2017|Diabetes Bites, March 2017 Newsletter|

How good is the performance and usability of the FreeStyle® Libre™ Flash glucose monitoring system (Abbott Diabetes Care, Alameda, CA) for interstitial glucose results compared with capillary blood glucose results?

Participate in a survey: pregnancy with type 1 diabetes – by Glu

By | March 16th, 2017|Diabetes Bites, March 2017 Newsletter|

Have you gone through pregnancy with type 1 diabetes? Are you considering a pregnancy? The research and surveys done through Glu surveys up to this point has already shown that there insufficient published literature about past pregnancy management. This new survey hopes to change this.

Can when you eat affect heart health?

By | February 21st, 2017|Diabetes Bites, February 2017 Newsletter|

Cow's milk has been thought to be a possible risk factor for the development of Type 1 diabetes. New research shows that while most cow's milk formulas do not raise the risk, one type of baby formula could be linked to a greater chance of developing Type 1 when given in the first week of life.

Expecting Mothers: Most cow’s milk formulas do not raise risk of Type 1 Diabetes

By | February 21st, 2017|Diabetes Bites, February 2017 Newsletter|

Cow's milk has been thought to be a possible risk factor for the development of Type 1 diabetes. New research shows that while most cow's milk formulas do not raise the risk, one type of baby formula could be linked to a greater chance of developing Type 1 when given in the first week of life.

Tresiba gains FDA approval for use in children and adolescents

By | January 18th, 2017|Diabetes Bites, January 2017 Newsletter|

Children and adolescents age 1 and up now have another option in basal insulin. On December 19, 2016, Novo Nordisk announced that the FDA approved an expanded indication for Tresiba (insulin degludec injection 100 U/mL, 200 U/mL).